Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis
- PMID: 25973276
- PMCID: PMC4418003
- DOI: 10.1155/2015/829439
Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis
Abstract
Introduction. Prostate cancer is the most common cancer among men in USA. The surgical outcomes of prostate cancer remain inconsistent. Barriers such as socioeconomic factors may play a role in patients' decision of refusing recommended cancer-directed surgery. Methods. The Nebraska Cancer Registry data was used to calculate the proportion of prostate cancer patients recommended the cancer-directed surgery and the surgery refusal rate. Multivariate logistic regression was applied to analyze the socioeconomic indicators that were related to the refusal of surgery. Results. From 1995 to 2012, 14,876 prostate cancer patients were recommended to undergo the cancer-directed surgery in Nebraska, and 576 of them refused the surgery. The overall refusal rate of surgery was 3.9% over the 18 years. Patients with early-stage prostate cancer were more likely to refuse the surgery. Patients who were Black, single, or covered by Medicaid/Medicare had increased odds of refusing the surgery. Conclusion. Socioeconomic factors were related to the refusal of recommended surgical treatment for prostate cancer. Such barriers should be addressed to improve the utilization of surgical treatment and patients' well-being.
Figures
References
-
- US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-Based Report. Atlanta, Ga, USA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014.
-
- Surveillance Epidemiology and End Results Program. Cancer of the Prostate—SEER Stat Fact Sheets. Surveillance Epidemiology and End Results Program; 2015. http://seer.cancer.gov/statfacts/html/prost.html.
-
- National Cancer Institute. Prostate Cancer Treatment (PDQ) 2015. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessi....
-
- Moon T. D., Brawer M. K., Wilt T. J. Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. Journal of the National Cancer Institute. Monographs. 1994;(19):69–71. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
